01
Dr. Reddy's announces Q3 FY10 results
View Results
Download Media pack
02
Exploit your strengths before exploring further
Dr. Reddy's is today a more nimble and agile organisation, thanks to the various lessons learnt along the way.
View Article
03
Dr. Reddy’s announces expansion plan of its Shreveport, Louisiana facility.
- Expansion represents up to $16.5 million in capital investment.
View Details
04
Dr. Reddy's bags the NASSCOM-CNBC IT User Award again!
View Details
05
Dr. Reddy's lauded for Corporate Social Responsibility at the CNBC - IBLA 2009
View Details
06
Dr. Reddy's bags award at the SAFA Best Presented Accounts Awards 2008
View Details
07
Dr. Reddy's launches Sustainability Report 2009
View Microsite
View Summary Report
08
Dr. Reddy's announces Q2 FY10 results
View Results
Download Media pack
09
Dr. Reddy's joins American Chemical Society Green Chemistry Institute® Pharmaceutical Roundtable as an associate member.
View Press release
10
Our Support for flood victims
Media Information Note
1010
Dr. Reddy's launches Strea™ Professional in India
View Pressrelease
08
Promius Pharma Launches Promiseb™ Cream
View Pressrelease
09
Dr. Reddy’s launches Finrid™ in India
View Pressrelease
10
Dr. Reddy's Annual General Meeting
July 22, 2009, Hyderabad
View Details
10121
Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F
View Press Release
View 20-F Filing
10
Dr. Reddy’s Annual Report 2008-09 released
View Report
10
Dr. Reddy’s launches Bispec™ in India
View Press Release
10
Dr. Reddy’s announces strategic alliance with GSK for Emerging Markets
View Press Release
09
Dr. Reddy’s announces ANDA approval of Omeprazole Mg OTC
View Press Release
10
Dr. Reddy's conducts Analysts and
Investors Meet
21st May, 2009
Mumbai
Click here to View Presentation
10
Dr. K Anji Reddy receives AIF (American India Foundation) Award 2009
Read More
10
Dr. Reddy’s inaugurates its Leadership Academy.
The Leadership Academy is a one stop resource center for leadership development, training and development needs for the global workforce of Dr. Reddy’s.
100
Dr. Reddy’s announces Q4 FY09 results.
Dr. Reddy’s FY09 Revenues at Rs. 69,441 million, EBITDA at Rs. 14,505 million
View Press Release
1010
Dr. Reddy’s Laboratories announce settlement of Clarinex® (Desloratadine) ANDA patent litigation with Schering Corporation and Sepracor Inc
101
Dr. Reddy’s (betapharm) receives preliminary results on AOK tender in Germany.
betapharm has been tentatively offered 8 products in different regions of Germany covering the AOK-insured persons.
10
Dr. Reddy’s honoured at the HDMA Annual Leadership Forum.
Dr. Reddy’s North America Generic Team was recently honoured at the HDMA Annual Leadership Forum held in Washington DC.
109
RedituxTM named ‘Product of the Year 2008’ by the Indian biotechnology magazine BioSpectrum.
Reditux was declared “Product of the Year” by the Indian biotechnology magazine, Biospectrum on Dec 12, 2008. It is a tribute to the efforts of the Biologics team of Dr. Reddy's
111
Dr. Reddy’s launches authorized generic version of Imitrex®* Tablets.
Dr. Reddy’s became the first company to launch an authorized generic version of GlaxoSmithKline’s Imitrex® (sumatriptan succinate) tablets (25mg, 50mg, and 100mg ) in the US market
10
Dr. Reddy’s wins the ‘Company with Best CSR & Sustainability Practices 2008’ award.
Dr. Reddy’s was conferred the ‘Company with Best CSR & Sustainability Practices 2008’ by The Asian Centre for Corporate Governance & Sustainability and the Indian Merchants Chamber.
